08:32 EDT AbbVie (ABBV) to acquire Capstan Therapeutics for $2.1B in cash at closing
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks